Funding for this research was provided by:
GSK Consumer Healthcare
Received: 29 April 2022
Accepted: 9 December 2022
First Online: 24 December 2022
: The final study protocol and amendments, informed consent, and other relevant information were approved by the 15 ethics committees at each of the 15 participating sites listed in the Methods section in accordance with China’s good clinical practice and other applicable China-specific requirements. The study was conducted in accordance with International Conference on Harmonisation and the ethical principles of the Declaration of Helsinki. Written, informed consent was obtained from each subject prior to any study-specific procedures.
: Not applicable.
: FY, JM, HX, RA, FZ, WL, WW, and WZ are investigators for GSK Consumer Healthcare.PZ, TL, FBR, MA, SP, and SM are employees of GSK Consumer Healthcare.JZ was an employee of GSK Consumer Healthcare at the time of this study.